Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1955 1
1958 1
1959 4
1960 3
1961 7
1962 9
1963 7
1964 14
1965 12
1966 22
1967 20
1968 16
1969 19
1970 17
1971 14
1972 19
1973 22
1974 12
1975 17
1976 18
1977 26
1978 29
1979 24
1980 35
1981 27
1982 30
1983 40
1984 42
1985 32
1986 37
1987 35
1988 32
1989 33
1990 37
1991 45
1992 51
1993 50
1994 61
1995 52
1996 91
1997 54
1998 87
1999 83
2000 101
2001 103
2002 105
2003 110
2004 143
2005 154
2006 180
2007 187
2008 268
2009 263
2010 355
2011 398
2012 418
2013 466
2014 457
2015 487
2016 527
2017 494
2018 579
2019 635
2020 757
2021 845
2022 807
2023 812
2024 387

Text availability

Article attribute

Article type

Publication date

Search Results

10,186 results

Results by year

Filters applied: . Clear all
Page 1
Beyond "Can we?".
Dimitrov K, Jain SK, Olson APJ. Dimitrov K, et al. Among authors: jain sk. J Hosp Med. 2024 Jan;19(1):75-76. doi: 10.1002/jhm.13213. Epub 2023 Oct 4. J Hosp Med. 2024. PMID: 37792420 No abstract available.
Sleep and Epilepsy.
Liu WK, Kothare S, Jain S. Liu WK, et al. Among authors: jain s. Semin Pediatr Neurol. 2023 Dec;48:101087. doi: 10.1016/j.spen.2023.101087. Epub 2023 Sep 24. Semin Pediatr Neurol. 2023. PMID: 38065633 Review.
PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma.
Wartewig T, Daniels J, Schulz M, Hameister E, Joshi A, Park J, Morrish E, Venkatasubramani AV, Cernilogar FM, van Heijster FHA, Hundshammer C, Schneider H, Konstantinidis F, Gabler JV, Klement C, Kurniawan H, Law C, Lee Y, Choi S, Guitart J, Forne I, Giustinani J, Müschen M, Jain S, Weinstock DM, Rad R, Ortonne N, Schilling F, Schotta G, Imhof A, Brenner D, Choi J, Ruland J. Wartewig T, et al. Among authors: jain s. Nat Cancer. 2023 Oct;4(10):1508-1525. doi: 10.1038/s43018-023-00635-7. Epub 2023 Sep 18. Nat Cancer. 2023. PMID: 37723306 Free PMC article.
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.
Guo C, Sharp A, Gurel B, Crespo M, Figueiredo I, Jain S, Vogl U, Rekowski J, Rouhifard M, Gallagher L, Yuan W, Carreira S, Chandran K, Paschalis A, Colombo I, Stathis A, Bertan C, Seed G, Goodall J, Raynaud F, Ruddle R, Swales KE, Malia J, Bogdan D, Tiu C, Caldwell R, Aversa C, Ferreira A, Neeb A, Tunariu N, Westaby D, Carmichael J, Fenor de la Maza MD, Yap C, Matthews R, Badham H, Prout T, Turner A, Parmar M, Tovey H, Riisnaes R, Flohr P, Gil J, Waugh D, Decordova S, Schlag A, Calì B, Alimonti A, de Bono JS. Guo C, et al. Among authors: jain s. Nature. 2023 Nov;623(7989):1053-1061. doi: 10.1038/s41586-023-06696-z. Epub 2023 Oct 16. Nature. 2023. PMID: 37844613 Free PMC article.
The next decade of Healthcare.
Stevens JP, Navathe A, Jain S. Stevens JP, et al. Among authors: jain s. Healthc (Amst). 2024 Mar;12(1):100737. doi: 10.1016/j.hjdsi.2024.100737. Epub 2024 Feb 29. Healthc (Amst). 2024. PMID: 38428063 No abstract available.
Brachial Neuritis.
Al Khalili Y, Jain S, Lam JC, DeCastro A. Al Khalili Y, et al. Among authors: jain s. 2024 Feb 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2024 Feb 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29763017 Free Books & Documents.
Anticancer mechanisms of β-carbolines.
Mishra S, Gupta A, Jain S, Vaidya A. Mishra S, et al. Among authors: jain s. Chem Biol Drug Des. 2024 Apr;103(4):e14521. doi: 10.1111/cbdd.14521. Chem Biol Drug Des. 2024. PMID: 38653576 Review.
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.
Vos JL, Burman B, Jain S, Fitzgerald CWR, Sherman EJ, Dunn LA, Fetten JV, Michel LS, Kriplani A, Ng KK, Eng J, Tchekmedyian V, Haque S, Katabi N, Kuo F, Han CY, Nadeem Z, Yang W, Makarov V, Srivastava RM, Ostrovnaya I, Prasad M, Zuur CL, Riaz N, Pfister DG, Klebanoff CA, Chan TA, Ho AL, Morris LGT. Vos JL, et al. Among authors: jain s. Nat Med. 2023 Dec;29(12):3077-3089. doi: 10.1038/s41591-023-02518-x. Epub 2023 Aug 24. Nat Med. 2023. PMID: 37620627 Clinical Trial.
Editorial: CRISPR tools, technology development, and application.
Suprasanna P, Klimek-Chodacka M, Jain SM. Suprasanna P, et al. Among authors: jain sm. Front Plant Sci. 2023 Nov 13;14:1329780. doi: 10.3389/fpls.2023.1329780. eCollection 2023. Front Plant Sci. 2023. PMID: 38023829 Free PMC article. No abstract available.
Racemose neurocysticercosis: a case series.
Sharma S, Singh A, Mani VE, Mishra SC, Chaturvedi P, Jain S, Kumar S, Jain N. Sharma S, et al. Among authors: jain s. BJR Case Rep. 2024 Jan 19;10(1):uaae001. doi: 10.1093/bjrcr/uaae001. eCollection 2024 Jan. BJR Case Rep. 2024. PMID: 38352260 Free PMC article. Review.
10,186 results
You have reached the last available page of results. Please see the User Guide for more information.